Transglutaminase reactivity of human involucrin

Skin Pharmacology and Applied Skin Physiology

Volumn 13, Issue 1, 2000, Pages 17-30

  Lambert, Adam ^a   Ekambaram, Meena ^a   Robinson, Nancy ^a   Eckert, Richard L ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Cornified envelope; Cross linking; Differentiation; Isopeptide bond; Keratinocyte; Transglutaminase

Indexed keywords

CARBON 14; INVOLUCRIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PUTRESCINE;

ANIMAL CELL; ARTICLE; CHEMICAL BOND; CHEMICAL REACTION; CONTROLLED STUDY; ENZYME SUBSTRATE COMPLEX; HUMAN; HUMAN CELL; ISOTOPE LABELING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING;

EID: 0033952856     PISSN: 14222868     EISSN: None     Source Type: Journal    
DOI: 10.1159/000029905     Document Type: Article

References (57)

1. Eckert RL, Crish JF, Robinson NA: The epidermal keratinocyte as a model for the study of gene regulation and cell differentiation. Physiol Rev 1997;77:397-424.
2. Eckert RL, Yaffe MB, Crish JF, Murthy S, Rorke EA, Welter JF: Involucrin - Structure and role in envelope assembly. J Invest Dermatol 1993;100:613-617.
3. Steinert PM, Marekov LN: The proteins clafin, filaggrin, keratin intermediate filaments, loricrin, and small proline-rich proteins 1 and 2 are isodipeptide cross-linked components of the human epidermal cornified cell envelope. J Biol Chem 1995;270:17702-17711.
4. Yoneda K, McBride OW, Korge BP, Kim IG, Steinert PM: The cornified cell envelope: Loricrin and transglutaminases. J Dermatol 1992;19: 761-764.
5. Rice RH, Green H: Presence in human epidermal cells of a soluble protein precursor of the cross-linked envelope: Activation of the cross-linking by calcium ions. Cell 1979;18: 681-694.
6. Green H: The keratinocyte as differentiated cell type. Harvey Lect 1980;74:101-139.
7. Goldsmith LA: Human epidermal transglutaminase. J Invest Dermatol 1983;80(suppl):39s-41s.
8. Leask A, Rosenberg M, Vassar R, Fuchs E: Regulation of human epidermal keratin gene: Sequences and nuclear factors involved in keratinocyte-specific transcription. Gene Dev 1990;4:1985-1998.
9. Thacher SM, Rice RH: Keratinocyte-specific transglutaminase of cultured human epidermal cells: Relation to cross-linked envelope formation and terminal differentiation. Cell 1985;40:685-695.
10. Chakravarty R, Rong XH, Rice RH: Phorbol ester-stimulated phosphorylation of keratinocyte transglutaminase in the membrane anchorage region. Biochem J 1990;271:25-30.
11. Chakravarty R, Rice RH: Acylation of keratinocyte transglutaminase by palmitic and myristic acids in the membrane anchorage region. J Biol Chem 1989;264:625-629.
12. Yaffe MB, Beegen H, Eckert RL: Biophysical characterization of involucrin reveals a molecule ideally suited to function as an intermolecular cross-bridge of the keratinocyte cornified envelope. J Biol Chem 1992; 267:12233-12238.
13. LaCelle PT, Lambert A, Ekambaram MC, Robinson NA, Eckert RL: In vitro cross-linking of recombinant human involucrin. Skin Pharmacol Appl Skin Physiol 1998;11: 214-226.
14. Eckert RL, Green H: Structure and evolution of the human involucrin gene. Cell 1986;46:583-589.
15. Etoh Y, Simon M, Green H: Involucrin acts as a transglutaminase substrate at multiple sites. Biochem Biophys Res Commun 1986;136: 51-56.
16. Simon M, Green H: Enzymatic cross-linking of involucrin and other proteins by keratinocyte particulates in vitro. Cell 1985;40:677-683.
17. Steinert PM, Marekov LN: Direct evidence that involucrin is a major early isopeptide cross-linked component of the keratinocyte cornified cell envelope. J Biol Chem 1997; 272:2021-2030.
18. Robinson NA, Ecken RL: identification of transglutaminasc reactive residues in S10011. J Biol Chem 1998;273:2721-2728.
19. Heinrikson RL, Meredith SC: Amino acid analysis by reverse-phase high-performance liquid chromatography: Precolumn derivatization with phenylisothiocyanate. Anal Biochem 1984;136:65-74.
20. Phillips MA, Qin Q, Mehrpouyan M, Rice RH: Keratinocyte transglutaminase membrane anchorage: Analysis of site-directed mutants. Biochemistry 1993;32:11057-11063.
21. Rice RH, Rong XH, Chakravarty R: Proteolytic release of keratinocyte transglutaminase. Biochem J 1990: 265:351-357.
22. Simon M, Green H: Participation of membrane-associated proteins in the formation of the cross-linked envelope of the keratinocyte. Cell 1984;36:827-834.
23. Simon M, Green H: The glutamine residues reactive in transglutaminase-catalyzd cross-linking of involucrin. J Biol Chem 1988;263: 18093-18098.
24. Robinson NA, LaCelle PT, Eckert RL: Involucrin is a covalently cross-linked constituent of highly purified epidermal corneocytes: Evidence for a common pattern of involucrin cross-linking in vivo and in vitro. J Invest Dermatol 1996:107:101-107.
25. Robinson NA, Lapic S, Welter JF, Eckert RL: S100A11, S100a10, annexin I, desmosomal proteins, SPRs, plasminogen activator inhibitor-2, and involucrin are components of the cornified envelope of cultured human epidermal keratinocytes. J Biol Chem 1997:272: 12035-12046.
26. Ballestar E, Abad C, Franco L: Core histones are glutaminyl substrates for tissue transglutaminase. J Biol Chem 1996;271:18817-18824.
27. Kojima S, Inui T, Muramatsu H, Suzuki Y. Kadomatsu K, Yoshizawa M, Hirose S. Kimura T, Sakakihara S, Muramatsu T: Dimerization of midkine by tissue transglutaminase and its functional implication. J Biol Chem 1997;272:9410-9416.
28. Mahoney SA, Perry M, Seddon A, Bohlen P, Haynes L: Transglutaminase forms midkine homodimers in cerebellar neurons and modulates the neurite-outgrowth response. Biochem Biophys Res Commun 1996; 224:147-152.
29. Perry MJ, Mahoney SA, Haynes LW: Transglutaminase C in cerebellar granule neurons: Regulation and localization of substrate cross-linking. Neuroscience 1995;65:1063-1076.
30. Kojima S. Muramatsu H. Amanuma H, Muramatsu T: Midkine enhances fibrinolytic activity of bovine endothelial cells. J Biol Chem 1995;270:9590-9596.
31. Kaartinen MT, Pirhonen A, Linnala Kankkunen A, Maenpaa PH: Transglutaminase-catalyzed cross-linking of osteopontin is inhibited by osteocalcin. J Biol Chem 1997;272: 22736-22741.
32. Mehul B, Bawumia S. Hughes RC: Cross-linking of galectin 3, a galactose-binding protein of mammalian cells, by tissue-type transglutaminase. FEBS Lett 1995;360:160-164.
33. Beninati S, Nicolini L. Jakus J, Passeggio A, Abbruzzese A: Identification of a substrate site for transglutaminases on the human protein synthesis initiation factor 5A. Biochem J 1995;305:725-728.
34. Jensen PH, Schuler E, Woodrow G, Richardson M, Goss N, Hojrup P, Petersen TE, Rasmussen LK: A unique interhelical insertion in plasminogen activator inhibitor-2 contains three glutamines, Gln83, Gln84. Gln86, essential for transglutaminase-mediated cross-linking. J Biol Chem 1994;269:15394-15.398.
35. Ikura K, Takahata K, Sasaki R: Cross-linking of a synthetic partial-length (1-28) peptide of the Alzheimer beta/A4 amyloid protein by transglutaminase. FEBS Lett 1993; 326:109-111.
36. Clement S, Velasco PT, Murthy SN, Wilson JH. Lukas TJ, Goldman RD. Lorand L: The intermediate filament protein, vimentin, in the lens is a target for cross-linking by transglutaminase. J Biol Chem 1998;273: 7604-7609.
37. Hunter I, Sigmundsson K, Beauchemin N, Obrink B: The cell adhesion molecule C-CAM is a substrate for tissue transglutaminase. FEBS Lett 1998:425:141-144.
38. Molberg O, Mcadam SN, Korner R, Quarsten H, Kristiansen C, Madsen L. Fugger L. Scott H, Noren O. Roepstorff P, Lundin KE, Sjostrom H. Sollid LM: Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease (see comments). Nat Med 1998;4:713-717.
39. Gentile V. Sepe C, Calvani M, Melone MA, Cotrufo R, Cooper AJ. Blass JP, Peluso G: Tissue transglutaminase-catalyzed formation of high-molecular-weight aggregates in vitro is favored with long polyglutaminc domains: A possible mechanism contributing to CAG-triplet diseases. Arch Biochem Biophys 1998:352:314-321.
40. Cooper AJL. Sheu KR, Burke JR, Onodcra O, Strittmatter WJ. Roses AD. Blass JP: Transglutaminase-catalyzed inactivation of glyceraldehyde 3-phosphate dehydrogenase and alpha-ketoglutarate dehydrogenase complex by polyglutamine domains of patholgocial length. Proc Natl Acad Sci USA 1997;94:12604-12609.
41. Umar S, Malavasi F, Mehta K: Post-translational modification on CD38 protein into a high molecular weight form alters its catalytic properties. J Biol Chem 1996;271:15922-15927.
42. Eligula L, Chuang L, Phillips ML. Motoki M, Seguro K, Muhlrad A: Transglutaminase-induced cross-linking between subdomain 2 of G-actin and the 636-642 lysine-rich loop of myosin subfragment 1. Biophys J 1998;74:953-963.
43. Nemes Z Jr, Adany R. Balazs M. Boross P. Fesus L: Identification of cytoplasmic actin as an abundant glutaminyl substrate for tissue transglutaminase HL-60 and U937 cells undergoing apoptosis. J Biol Chem 1997:272:20577-20583.
44. Miller ML, Johnson GV: Transglutaminase cross-linking of the tau protein. J Neurochem 1995;65: 1760-1770.
45. Oliverio S, Amendola A, Di Sano F, Farrace MC, Fesus L, Nemes Z, Piredda L, Spinedi A, Piacentini M: Tissue transglutaminase-dependent posttranslational modification of the retinoblastoma gene product in promonocytic cells undergoing apoptosis. Mol Cell Biol 1997;17: 6040-6048.
46. Nunes I, Gleizes PE, Metz CN, Rifkin DB: Latent transforming growth factor-beta binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-beta. J Cell Biol 1997;136:1151-1163.
47. Peter A, Lilja H, Lundwall A. Malm J: Semenogelin I and semenogelin II, the major gel-forming proteins in human semen, are substrates for transglutaminase. Eur J Biochem 1998;252:216-221.
48. Grootjans JJ, Groenen PJ, de Jong WW: Substrate requirements for transglutaminases. Influence of the amino acid residue preceding the amine donor lysine in a native protein. J Biol Chem 1995;270:22855-22858.
49. Loewy AG, Blodgett JK, Blase FR, May MH: Synthesis and use of a substrate for the detection of isopeptidase activity. Anal Biochem 1997; 246:111-117.
50. Hettasch JM, Greenberg CS: Analysis of the catalytic activity of human factor XIIIa by site-directed mutagenesis. J Biol Chem 1994;269: 28309-28313.
51. Lai TS, Achyuthan KE, Santiago MA, Greenberg GS: Carboxyl-terminal truncation of recombinant factor XIII A-chains. Characterization of minimum structural requirement for transglutaminase activity. J Biol Chem 1994;269:24596-24601.
52. Halkier T, Andersen H, Vestergaard A, Magnusson S: Bovine histidinerich glycoprotein is a substrate for bovine plasma factor XIIIa. Biochem Biophys Res Commun 1994; 200:78-82.
53. Steinert PM: A model for the hierarchical structure of the human epidermal cornified cell envelope. Cell Death Diff 1995;2:33-40.
54. Groenen PJ, Smulders RH, Peters RF, Grootjans JJ, van den Ijssel PR, Bloemendal H, de Jong WW: The amine-donor substrate specificity of tissue-type transglutaminase. Influence of amino acid residues flanking the amine-donor lysine residue. Eur J Biochem 1994:220:795-799.
55. Kahlem P, Terre C, Green H, Djian P: Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed cross-linking: Relevance to diseases of the nervous system (see comments). Proc Natl Acad Sci USA 1996:93:14580-14585.
56. Cooper AJ, Sheu KF, Burke JR, Onodera O, Strittmatter WJ, Roses AD, Blass JP: Polyglutamine domains are substrates of tissue transglutaminase: Does transglutaminase play a role in expanded CAG/pol-Q neurodegenerative diseases? J Neurochem 1997;69:431-414.
57. Nemes Z, Marekov LN, Steinert PM: Involucrin cross-linking by transglutaminase 1. Binding to membranes directs residue specificity. J Biol Chem 1999;274:11013-11021.